STK17A and prostate carcinoma: To determine if DRAK1 is induced in prostate cancer cells in response to RNase L activation, PC3 and DU145 cells were transfected with 2–5A or synthetic dsRNA, Poly I:C, which activates oligoadenylate synthetase to produce 2–5A.